New method of targeting mutant RAS provides hope for cancer patients
Researchers have demonstrated a new therapeutic way to block a protein that is frequently mutated in cancers. This work, which involves inhibiting the oncogenic protein RAS using small molecules, lays a strong foundation for the development of clinical anti-cancer therapies.
Materials provided by Medical University of South Carolina. Original written by Caroline Wallace. Note: Content may be edited for style and length.
Source link aaaaa